Research Project
Grant-in-Aid for Young Scientists (B)
Detoxifying enzyme glyoxalase 1 (GLO1) is known to be involved in the development of diabetes and its complications. However, the transcriptional regulation of GLO1 is not yet fully understood. In this study, we have identified novel polymorphisms in the human GLO1 promoter region. One of the polymorphisms was found to significantly upregulate the transcription of GLO1. We next addressed to reveal molecular mechanisms under the upregulation of the GLO1 transcription. As a result, the recruitment of histone proteins and the epigenetic modifications were involved in the transcriptional regulation. Cell culture conditions such as high glucose concentration or normoxia could change the frequency of the polymorphisms of the GLO1 gene. The polymorphisms were also found to link to the development of advanced diabetic vascular complications. These findings will offer a possible new avenue for the prevention and the treatment of GLO1-related diseases.
All 2018 2017 2016 2015
All Journal Article (8 results) (of which Int'l Joint Research: 2 results, Peer Reviewed: 6 results, Open Access: 4 results) Presentation (9 results) (of which Int'l Joint Research: 1 results) Patent(Industrial Property Rights) (2 results)
Oncology Lett
Volume: 15 Pages: 4627-4634
120006605140
Cancer Med
Volume: in press
120006605139
IMARS Highlights
Volume: 12 Pages: 5-7
Sci Rep
Volume: 11 Pages: 1-15
Oncology Rep
Mol Med Rep
J. Diabetes Res
Volume: 1786789 Pages: 1-10
10.1155/2016/1786789
Gastric Cancer
Volume: 18 Issue: 4 Pages: 1-14
10.1007/s10120-015-0579-8
40020959187